Autologous cord blood mononuclear cell infusion for the prevention of bronchopulmonary dysplasia in very preterm monozygotic twins: A study protocol for a randomized, placebo-controlled, double-blinded multicenter trial

Autologous cord blood mononuclear cell infusion for the prevention of bronchopulmonary dysplasia in very preterm monozygotic twins: A study protocol for a randomized, placebo-controlled, double-blinded multicenter trial

BackgroundPreterm-associated complications remain the main cause of neonatal death. Survivors face the challenges of short- and long-term complications. Among all complications, bronchopulmonary dysplasia (BPD) remains the first important cause of neonatal mortality and morbidity. Current treatment...

Full description

Bibliographic Details
Main Authors: Ren Zhuxiao, Huang Ruoyu, Yang Liling, Ren Xuejun, Yang Chunhui, Ruan Wanfen, Chen Zhifeng, Dai Yiheng, Zhang Qi, Wei Wei, Liu Zhipeng, Pei Jingjun, Yin Qigai, Yang Jie
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Pediatrics
Subjects:
cord blood mononuclear cells
bronchopulmonary dysplasia
very preterm monozygotic twins
prevention
autologous
study protocol
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.884366/full

Similar Items

Similar Items